title: Influenza vaccination and associated factors among Korean cancer survivors : a cross-sectional analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.
abstract: Influenza vaccination is important for cancer survivors, a population with impaired immunity. This study was designed to assess influenza vaccination patterns among Korean cancer survivors. In this cross-sectional analysis, data were obtained from standardized questionnaires from 943 cancer survivors and 41,233 non-cancer survivors who participated in the Fourth and Fifth Korea National Health and Nutrition Examination Surveys (2007-2011). We identified the adjusted influenza vaccination rates and assessed factors associated with influenza vaccination using multivariate logistic regression. Cancer survivors tended to have a higher adjusted influenza vaccination rate than the general population. The rates for influenza vaccination in specific cancer types such as stomach, hepatic, colon, and lung cancers were significantly higher than non-cancer survivors. Among all cancer survivors, those with chronic diseases, elderly subjects, and rural dwellers were more likely to receive influenza vaccination; those with cervical cancer were less likely to receive influenza vaccination. Cancer survivors were more likely to receive influenza vaccinations than non-cancer survivors, but this was not true for particular groups, especially younger cancer survivors. Cancer survivors represent a sharply growing population; therefore, immunization against influenza among cancer survivors should be concerned as their significant preventative healthcare services.
authors.affiliation: Center for Health Promotion & Cancer Prevention, Dongnam Institute of Radiological & Medical Sciences, Busan, Korea.
authors.forename: Kyung-Hyun
authors.identifier: 0000-0002-0097-4361
authors.initials: KH
authors.lastname: Choi
authors.affiliation: Department of Family Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
authors.forename: Sang Min
authors.identifier: 0000-0002-7498-4829
authors.initials: SM
authors.lastname: Park
authors.affiliation: JW LEE Center for Global Medicine and Department of Family Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, Korea.
authors.forename: Kiheon
authors.identifier: 0000-0002-7139-2342
authors.initials: K
authors.lastname: Lee
authors.affiliation: Department of Family Medicine, National Police Hospital, Seoul, Korea.
authors.forename: Ju Hyun
authors.identifier: 0000-0001-8623-0744
authors.initials: JH
authors.lastname: Lee
authors.affiliation: Department of Family Medicine, Dong-A University College of Medicine, Busan, Korea.
authors.forename: Joo-Sung
authors.identifier: 0000-0001-7032-5298
authors.initials: JS
authors.lastname: Park
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D004198:Disease Susceptibility / Q000401:mortality; D004522:Educational Status; D005260:Female; D015438:Health Behavior; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000401:mortality* / Q000517:prevention & control*; D008297:Male; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality*; D056910:Republic of Korea / Q000453:epidemiology; D012307:Risk Factors; D017678:Sex Distribution; D012923:Social Class; D015996:Survival Rate; D017741:Survivors / Q000706:statistics & numerical data*
chemical_list: D007252:Influenza Vaccines
keywords: Cancer Survivors; Influenza Vaccines; Korean